These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2756522)

  • 1. [Hepatitis during treatment with tamoxifen. Effects on the kinetics of epirubicin].
    Bressollette L; Swirsky H; Kernaleguen D; Carlhant D; Fauquert P; Le Bot MA; Baccino E; Riche C
    Therapie; 1989; 44(2):151-2. PubMed ID: 2756522
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen-associated steatohepatitis--report of three cases.
    Pinto HC; Baptista A; Camilo ME; de Costa EB; Valente A; de Moura MC
    J Hepatol; 1995 Jul; 23(1):95-7. PubMed ID: 8530816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
    Satoh Y; Une Y; Fujisawa J; Uchino J
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2509-12. PubMed ID: 7944500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Viral Hepatitis A over imposed on chronic hepatic damage due to tamoxifen: report of a case].
    Vildozola H; Vargas G; Takano J
    Rev Gastroenterol Peru; 2007; 27(1):67-71. PubMed ID: 17431437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epirubicin-induced primary Sjögren's syndrome.
    Oxholm A; Frederiksen PL; Oxholm P
    Lancet; 1986 Sep; 2(8507):629-30. PubMed ID: 2875341
    [No Abstract]   [Full Text] [Related]  

  • 6. Tamoxifen-associated hepatocellular damage and agranulocytosis.
    Ching CK; Smith PG; Long RG
    Lancet; 1992 Apr; 339(8798):940. PubMed ID: 1348345
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen and liver damage.
    Blackburn AM; Amiel SA; Millis RR; Rubens RD
    Br Med J (Clin Res Ed); 1984 Aug; 289(6440):288. PubMed ID: 6430441
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen-induced hypercalcemia in metastatic breast cancer.
    Nemoto T; Rosner DH; Patel DJ; Wettingfeld RF; Bambrah SS; Dao TL
    N Y State J Med; 1980 Dec; 80(13):1980-2. PubMed ID: 6937756
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen-induced steatohepatitis.
    Pratt DS; Knox TA; Erban J
    Ann Intern Med; 1995 Aug; 123(3):236. PubMed ID: 7598311
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate].
    Tsumura I; Okamura Y; Takatsuka Y; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1509-12. PubMed ID: 2143889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benign hepatic cyst in a patient on antiestrogen therapy for metastatic breast cancer.
    Nand S; Gordon LI; Brestan E; Harris C; Brandt T
    Cancer; 1982 Nov; 50(9):1882-3. PubMed ID: 7116312
    [No Abstract]   [Full Text] [Related]  

  • 12. Allopurinol hepatotoxicity potentiated by tamoxifen.
    Shah KA; Levin J; Rosen N; Greenwald E; Zumoff B
    N Y State J Med; 1982 Nov; 82(12):1745-6. PubMed ID: 6960280
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypercalcemia induced by tamoxifen.
    O'Connell TX
    Am J Surg; 1981 Feb; 141(2):277-8. PubMed ID: 7457749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen-related vasculitis.
    Baptista MZ; Prieto VG; Chon S; Hortobagyi GN; Esteva FJ
    J Clin Oncol; 2006 Jul; 24(21):3504-5. PubMed ID: 16849770
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of advanced breast cancer with multiple organ metastases successfully treated by tamoxifen].
    Shiba E; Kobayashi T; Takeda T; Miya A; Kawano I; Takai S; Mori T
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2255-8. PubMed ID: 1444494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A clinical report of high-dose epirubicin combined with cyclophosphamide and fluorouracil for advanced breast cancer].
    Feng J; Zheng X; Dai A
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):468-70. PubMed ID: 10920949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial.
    Bottini A; Berruti A; Brizzi MP; Bersiga A; Generali D; Allevi G; Aguggini S; Bolsi G; Bonardi S; Tondelli B; Vana F; Tampellini M; Alquati P; Dogliotti L
    Endocr Relat Cancer; 2005 Jun; 12(2):383-92. PubMed ID: 15947110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose tamoxifen in breast cancer bone metastasis.
    Stathopoulos GP; Trafalis D
    J BUON; 2013; 18(2):532-4. PubMed ID: 23818373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen-induced steatohepatitis.
    Van Hoof M; Rahier J; Horsmans Y
    Ann Intern Med; 1996 May; 124(9):855-6. PubMed ID: 8610959
    [No Abstract]   [Full Text] [Related]  

  • 20. [A case of hepatic arterial infusion chemotherapy for multiple liver metastasis from breast cancer].
    Hara S; Hashizume S; Itoyanagi N; Ayabe H; Tagawa Y; Tsuji H; Oka T; Yamamoto S; Shinguu H; Tou K; Tooyama H; Yamazumi K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1809-12. PubMed ID: 9382538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.